Vista OS vs Eko Low Ejection Fraction Tool (ELEFT)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Vista AI, Inc.
VS

AI Verdict

Tool A focuses on automating and enhancing the acquisition and analysis of cardiac MRI scans, improving efficiency and image quality in advanced diagnostics. Tool B, conversely, provides an AI-powered screening tool for early detection of low ejection fraction during routine physical exams using a digital stethoscope. While both are FDA-cleared cardiology AI tools, they serve distinct purposes within the patient care pathway, with Tool A optimizing imaging workflows and Tool B aiding in initial diagnostic screening.

Choose Vista OS if…

Choose Vista OS if your cardiology or radiology department aims to significantly enhance the efficiency and consistency of cardiac MRI acquisitions. This tool is ideal for facilities seeking to automate scan planning, reduce technologist workload, and ensure high-quality, standardized cardiac imaging across GE or Siemens MRI systems.

View Vista OS →

Choose Eko Low Ejection Fraction Tool (ELEFT) if…

Choose Eko Low Ejection Fraction Tool (ELEFT) if your clinical practice requires a rapid, non-invasive screening solution for early detection of low ejection fraction during routine physical examinations. This AI-powered tool is best suited for clinicians, including primary care and cardiology, who utilize Eko digital stethoscopes and want to proactively identify patients at risk for heart failure.

View Eko Low Ejection Fraction Tool (ELEFT) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Vista OS Eko Low Ejection Fraction Tool (ELEFT)
Pricing Not publicly disclosed. Unknown
Deployment Software-only solution; runs on a stand-alone Linux-based computer workstation; integrates with GE or Siemens MRI systems; designed for single- or multi-site deployment with secure remote access. Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools offer significant usability improvements within their respective clinical contexts. Vista OS streamlines complex cardiac MRI acquisition for technologists, making the workflow faster and more consistent. ELEFT integrates seamlessly into routine physical exams via a digital stethoscope, providing rapid, non-invasive screening results for a broader range of clinicians.

Clinical Value

Eko Low Ejection Fraction Tool (ELEFT)

ELEFT provides high clinical value by aiding in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams. This early identification can lead to earlier intervention and improved patient outcomes, especially in primary care settings where advanced diagnostics may not be readily available. The tool has undergone robust clinical validation in multi-site prospective studies.

Pricing & Value

Eko Low Ejection Fraction Tool (ELEFT)

While neither tool publicly discloses specific pricing, Eko's SENSORAu2122 platform, which includes ELEFT, has established CMS reimbursement with a payment rate of $128.90 per use. This provides a clear financial pathway for healthcare systems and demonstrates recognized value by payers, offering more transparency and a tangible return on investment compared to Vista OS's undisclosed pricing.

Enterprise Readiness

Eko Low Ejection Fraction Tool (ELEFT)

ELEFT explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are critical for enterprise adoption in healthcare. Furthermore, Eko provides a dedicated SENSORAu2122 Help Center with tailored guides for institution, program, clinician, and IT administrators, indicating a more mature and comprehensive approach to enterprise deployment and support.

Innovation

Eko Low Ejection Fraction Tool (ELEFT)

ELEFT demonstrates greater innovation by transforming a ubiquitous, traditional clinical tool like the stethoscope into an AI-powered diagnostic device for early heart failure detection. This integration into routine physical exams offers a novel and highly accessible approach to screening, potentially democratizing advanced cardiac diagnostics.

Support & Docs

Eko Low Ejection Fraction Tool (ELEFT)

Eko Health offers a more transparent and comprehensive support structure, including multiple contact channels like live Q&A sessions, 1:1 phone calls, email support, and a dedicated claims portal. Their specialized SENSORAu2122 Help Center for enterprise institutions provides extensive documentation and guides, surpassing the publicly available information for Vista OS.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Vista OS Eko Low Ejection Fraction Tool (ELEFT)
Product Name Vista OS Eko Low Ejection Fraction Tool (ELEFT)
Company Vista AI, Inc. Eko Health
Primary AI Function Automates and simplifies cardiac MRI acquisition, including scan planning, localization, parameter tuning, and real-time motion/artifact detection. Aids clinicians in the early detection of low ejection fraction by analyzing ECG and heart sound recordings.
Integration Integrates with GE or Siemens MRI systems; integrates with common PACS and post-processing software. Integrates with FDA-cleared Eko digital stethoscopes.
Target Specialties Cardiology, Radiology Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Vista OS and Eko Low Ejection Fraction Tool (ELEFT).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Vista OS is designed to automate and simplify cardiac MRI acquisition, integrating directly with GE or Siemens MRI systems to enhance consistency and productivity for radiology and cardiology departments. Eko Low Ejection Fraction Tool (ELEFT) integrates with Eko digital stethoscopes to provide rapid, non-invasive screening for low ejection fraction during routine physical exams, making it beneficial for early heart failure detection in primary care and cardiology settings.
Vista OS integrates with common PACS and post-processing software, facilitating data flow within the imaging workflow. While the broader VistA EHR system is a full-featured, open-source EHR, the AI Scan tool's direct integration with EHR systems for populating patient records with its AI-driven acquisition data would require further inquiry. ELEFT, as part of the SENSORAu2122 platform, explicitly integrates with Electronic Medical Records (EMRs) for seamless documentation, allowing for customization to fit health system needs. This enables the rapid low ejection fraction detection results to be incorporated into a patient's longitudinal record to inform clinical decision-making.
The provided information highlights Vista AI Scan's role in automating and simplifying cardiac MRI acquisition, enhancing consistency, productivity, and patient access to high-quality imaging, but specific diagnostic accuracy metrics are not detailed. Eko's Low Ejection Fraction Tool has been clinically validated, achieving an AUROC of 0.835 for detecting LVEF <40%, with 74.7% sensitivity and 77.5% specificity in a multi-site study of 3,456 patients. An independent validation by Imperial College London reported an AUROC of 0.85, 84.8% sensitivity, and 69.5% specificity.
Vista OS aims to automate and simplify cardiac MRI acquisition with features like automated scan planning in 30 seconds, suggesting a reduced learning curve for MRI technologists and a quick realization of operational benefits through increased productivity. ELEFT provides low ejection fraction detection results in approximately 15 seconds during a physical exam, indicating a fast integration into existing physician workflows and a rapid time-to-value for early heart failure screening.
Vista OS is explicitly designed for single- or multi-site deployment with secure remote access, suggesting built-in capabilities and support for broader rollouts across different facilities. ELEFT, being a cloud-based solution and part of the SENSORAu2122 enterprise platform, inherently offers scalability for multi-site deployment to flag cardiac diseases across various care encounters. However, specific details on centralized management and implementation support for larger health systems would be important to clarify with the vendor.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.